Persistently high venous-to-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock

Gustavo A Ospina-Tascón, Diego F Bautista-Rincón, Mauricio Umaña, José D Tafur, Alejandro Gutiérrez, Alberto F García, William Bermúdez, Marcela Granados, César Arango-Dávila, Glenn Hernández, Gustavo A Ospina-Tascón, Diego F Bautista-Rincón, Mauricio Umaña, José D Tafur, Alejandro Gutiérrez, Alberto F García, William Bermúdez, Marcela Granados, César Arango-Dávila, Glenn Hernández

Abstract

Introduction: Venous-to-arterial carbon dioxide difference (Pv-aCO2) may reflect the adequacy of blood flow during shock states. We sought to test whether the development of Pv-aCO2 during the very early phases of resuscitation is related to multi-organ dysfunction and outcomes in a population of septic shock patients resuscitated targeting the usual oxygen-derived and hemodynamic parameters.

Methods: We conducted a prospective observational study in a 60-bed mixed ICU in a University affiliated Hospital. 85 patients with a new septic shock episode were included. A Pv-aCO2 value ≥ 6 mmHg was considered to be high. Patients were classified in four predefined groups according to the Pv-aCO2 evolution during the first 6 hours of resuscitation: (1) persistently high Pv-aCO2 (high at T0 and T6); (2) increasing Pv-aCO2 (normal at T0, high at T6); (3) decreasing Pv-aCO2 (high at T0, normal at T6); and (4) persistently normal Pv-aCO2 (normal at T0 and T6). Multiorgan dysfunction at day-3 was compared for predefined groups and a Kaplan Meier curve was constructed to show the survival probabilities at day-28 using a log-rank test to evaluate differences between groups. A Spearman-Rho was used to test the agreement between cardiac output and Pv-aCO2. Finally, we calculated the mortality risk ratios at day-28 among patients attaining normal oxygen parameters but with a concomitantly increased Pv-aCO2.

Results: Patients with persistently high and increasing Pv-aCO2 at T6 had significant higher SOFA scores at day-3 (p < 0.001) and higher mortality rates at day-28 (log rank test: 19.21, p < 0.001) compared with patients who evolved with normal Pv-aCO2 at T6. Interestingly, a poor agreement between cardiac output and Pv-aCO2 was observed (r2 = 0.025, p < 0.01) at different points of resuscitation. Patients who reached a central venous saturation (ScvO)2 ≥ 70% or mixed venous oxygen saturation (SvO2) ≥ 65% but with concomitantly high Pv-aCO2 at different developmental points (i.e., T0, T6 and T12) had a significant mortality risk ratio at day-28.

Conclusion: The persistence of high Pv-aCO2 during the early resuscitation of septic shock was associated with more severe multi-organ dysfunction and worse outcomes at day-28. Although mechanisms conducting to increase Pv-aCO2 during septic shock are insufficiently understood, Pv-aCO2 could identify a high risk of death in apparently resuscitated patients.

Figures

Figure 1
Figure 1
Sequential Organ Failure Assessment scores at day 3 by the early development (first 6 hours) of mixed venous-to-arterial carbon dioxide difference. Kruskal–Wallis test, P <0.001. **Significant differences between persistently high mixed venous-to-arterial carbon dioxide difference (Pv-aCO2) and low Pv-aCO2 group; and between persistently high Pv-aCO2 and decreasing Pv-aCO2 group after Bonferroni correction. H-H, Pv-aCO2 high at Time 0 (T0) and 6 hours later (T6); L-H, Pv-aCO2 normal at T0 and high at T6; H-L, Pv-aCO2 high at T0 and normal at T6; and L-L, Pv-aCO2 normal at T0 and T6. SOFA, Sequential Organ Failure Assessment.
Figure 2
Figure 2
Survival probabilities at day 28 by the development of mixed venous-to-arterial carbon dioxide difference during the first 6 hours of resuscitation. Log-rank, Mantel–Cox: 19.21, P <0.001. H-H, mixed venous-to-arterial carbon dioxide difference (Pv-aCO2) high at Time 0 (T0) and 6 hours later (T6); L-H, Pv-aCO2 normal at T0 and high at T6; H-L, Pv-aCO2 high at T0 and normal at T6; and L-L, Pv-aCO2 normal at T0 and T6.
Figure 3
Figure 3
Scatter plot between cardiac index and mixed venous-to-arterial carbon dioxide difference. All patients at Time 0 (T0) and 6 hours (T6), 12 hours (T12) and 24 hours (T24) later. Pearson correlation: 0.16; r2 = 0.025; P <0.01. CI, confidence interval; Pv-aCO2, mixed venous-to-arterial carbon dioxide difference.
Figure 4
Figure 4
Lactate clearance (%) 6 and 12 hours after Time 0 for patients with normal or high mixed venous-to-arterial carbon dioxide difference at 6 hours. Significant differences for lactate clearance (Time 0 (T0) to 6 hours later (T6) and T0 to 12 hours later (T12)) between patients with persistently high (that is, high-to-high and normal-to-high groups) and normalized mixed venous-to-arterial carbon dioxide difference at T6 (high-to-normal and persistently low groups). A negative percent clearance indicates a reduction in lactate levels. Black bars: High Pv-aCO2 at T6; Gray bars: Low Pv-aCO2 at T6.
Figure 5
Figure 5
Correlation between mixed venous carbon dioxide pressure and central venous-to-arterial carbon dioxide difference. Scatter plot representing the mixed-venous to arterial carbon dioxide (Pvm-aCO2) difference versus the central-venous to arterial carbon dioxide difference (Pvc-aCO2). Pearson correlation: 0.71 (95% confidence interval: 0.47 to 0.86); R2 = 0.55, P <0.001.

References

    1. Beal AL, Cerra FB. Multiple organ failure syndrome in the, 1990’s. Systemic inflammatory response and organ dysfunction. JAMA. 1990;17:226–233.
    1. Shoemaker WC, Appel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med. 1988;17:1117–1120. doi: 10.1097/00003246-198811000-00007.
    1. Vallet B. Vascular reactivity and tissue oxygenation. Intensive Care Med. 1998;17:3–11. doi: 10.1007/s001340050507.
    1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med. 2001;17:1368–1377. doi: 10.1056/NEJMoa010307.
    1. Third European Consensus Conference in Intensive Care Medicine. Tissue hypoxia: How to detect, how to correct, how to prevent. Societe de reanimation de langue francaise. The American thoracic society. European society of intensive care medicine. Am J Respir Crit Care Med. 1996;17:1573–1578.
    1. Russell JA, Phang PT. The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med. 1994;17:533–537. doi: 10.1164/ajrccm.149.2.8306058.
    1. Marik PE, Bankov A. Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients. Crit Care Med. 2003;17:818–822. doi: 10.1097/01.CCM.0000054862.74829.EA.
    1. Grundler W, Weil MH, Rackow EC. Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation. 1986;17:1071–1074. doi: 10.1161/01.CIR.74.5.1071.
    1. Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI. Difference in acid–base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med. 1986;17:153–156. doi: 10.1056/NEJM198607173150303.
    1. Mecher CE, Rackow EC, Astiz ME, Weil MH. Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med. 1990;17:585–589. doi: 10.1097/00003246-199006000-00001.
    1. Adrogue HJ, Rashad MN, Gorin AB, Yacoub J, Madias NE. Assessing acid–base status in circulatory failure. Differences between arterial and central venous blood. N Engl J Med. 1989;17:1312–1316. doi: 10.1056/NEJM198905183202004.
    1. Kazarian KK, Del Guercio LR. The use of mixed venous blood gas determinations in traumatic shock. Ann Emerg Med. 1980;17:179–182. doi: 10.1016/S0196-0644(80)80002-3.
    1. Teboul JL, Mercat A, Lenique F, Berton C, Richard C. Value of the venous–arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine. Crit Care Med. 1998;17:1007–1010. doi: 10.1097/00003246-199806000-00017.
    1. Bakker J, Vincent JL, Gris P, Leon M, Coffernils M, Kahn RJ. Veno-arterial carbon dioxide gradient in human septic shock. Chest. 1992;17:509–515. doi: 10.1378/chest.101.2.509.
    1. Vallet B, Teboul JL, Cain S, Curtis S. Venoarterial CO(2) difference during regional ischemic or hypoxic hypoxia. J Appl Physiol. 2000;17:1317–1321.
    1. Neviere R, Chagnon JL, Teboul JL, Vallet B, Wattel F. Small intestine intramucosal PCO(2) and microvascular blood flow during hypoxic and ischemic hypoxia. Crit Care Med. 2002;17:379–384. doi: 10.1097/00003246-200202000-00019.
    1. Dubin A, Estenssoro E, Murias G, Pozo MO, Sottile JP, Baran M, Piacentini E, Canales HS, Etcheverry G. Intramucosal-arterial Pco2 gradient does not reflect intestinal dysoxia in anemic hypoxia. J Trauma. 2004;17:1211–1217. doi: 10.1097/01.TA.0000107182.43213.4B.
    1. Vallee F, Vallet B, Mathe O, Parraguette J, Mari A, Silva S, Samii K, Fourcade O, Genestal M. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med. 2008;17:2218–2225. doi: 10.1007/s00134-008-1199-0.
    1. Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, Richard C, Teboul JL. Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients. Intensive Care Med. 2002;17:272–277. doi: 10.1007/s00134-002-1215-8.
    1. van Beest PA, van Ingen J, Boerma EC, Holman ND, Groen H, Koopmans M, Spronk PE, Kuiper MA. No agreement of mixed venous and central venous saturation in sepsis, independent of sepsis origin. Crit Care Med. 2010;17:R219.
    1. van Beest PA, Lont MC, Holman ND, Loef B, Kuiper MA, Boerma EC. Central venous–arterial pCO(2) difference as a tool in resuscitation of septic patients. Intensive Care Med. 2013;17:1034–1039. doi: 10.1007/s00134-013-2888-x.
    1. van Beest PA, Hofstra JJ, Schultz MJ, Boerma EC, Spronk PE, Kuiper MA. The incidence of low venous oxygen saturation on admission to the intensive care unit: a multi-center observational study in The Netherlands. Crit Care Med. 2008;17:R33.
    1. Hernandez G, Pena H, Cornejo R, Rovegno M, Retamal J, Navarro JL, Aranguiz I, Castro R, Bruhn A. Impact of emergency intubation on central venous oxygen saturation in critically ill patients: a multicenter observational study. Crit Care Med. 2009;17:R63.
    1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2001;17:1250–1256.
    1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R. et al.Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;17:296–327. doi: 10.1097/01.CCM.0000298158.12101.41.
    1. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on ‘sepsis-related problems’ of the European Society of Intensive Care Medicine. Crit Care Med. 1998;17:1793–1800. doi: 10.1097/00003246-199811000-00016.
    1. Neviere R, Mathieu D, Chagnon JL, Lebleu N, Wattel F. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med. 1996;17:1684–1688. doi: 10.1164/ajrccm.154.6.8970355.
    1. Elizalde JI, Hernandez C, Llach J, Monton C, Bordas JM, Pique JM, Torres A. Gastric intramucosal acidosis in mechanically ventilated patients: role of mucosal blood flow. Crit Care Med. 1998;17:827–832. doi: 10.1097/00003246-199805000-00011.
    1. Tugtekin IF, Radermacher P, Theisen M, Matejovic M, Stehr A, Ploner F, Matura K, Ince C, Georgieff M, Trager K. Increased ileal-mucosal-arterial PCO2 gap is associated with impaired villus microcirculation in endotoxic pigs. Intensive Care Med. 2001;17:757–766. doi: 10.1007/s001340100871.
    1. Creteur J, De Backer D, Sakr Y, Koch M, Vincent JL. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med. 2006;17:516–523. doi: 10.1007/s00134-006-0070-4.
    1. De Backer D. Lactic acidosis. Intensive Care Med. 2003;17:699–702.
    1. Raza O, Schlichtig R. Metabolic component of intestinal PCO(2) during dysoxia. J Appl Physiol. 2000;17:2422–2429.
    1. Jakob SM, Kosonen P, Ruokonen E, Parviainen I, Takala J. The Haldane effect – an alternative explanation for increasing gastric mucosal PCO2 gradients? Br J Anaesth. 1999;17:740–746. doi: 10.1093/bja/83.5.740.
    1. Hurley R, Mythen MG. The Haldane effect – an explanation for increasing gastric mucosal PCO2 gradients? Br J Anaesth. 2000;17:167–169.
    1. Schlichtig R, Bowles SA. Distinguishing between aerobic and anaerobic appearance of dissolved CO2 in intestine during low flow. J Appl Physiol. 1994;17:2443–2451.

Source: PubMed

3
Abonner